Back to EARNEST PARTNERS LLC EARNEST PARTNERS LLC

CNMDCNMD
Showing 8 of 24 quarters

Position history for EARNEST PARTNERS LLCEARNEST PARTNERS LLC's holdings in CONMED CORP

EARNEST PARTNERS LLC holds 2.5M shares of CNMD (CONMED CORP), worth $82M as of 2026-Q2. The position was decreased (-2.5% shares). CNMD represents 0.3% of EARNEST PARTNERS LLC's portfolio.

Current Value

$82M

Current Shares

2.5M

Total Value Change

-$118.2M

Total Shares Change

-279,005

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2.5M
-2.5%
$82M0.3%$32.73
0
2026-Q1
Decreased
2.6M
-3.5%
$90.9M0.4%$35.36
0
2025-Q4
Decreased
2.7M
-4.8%
$108.1M0.5%$40.60
0
2025-Q3
Decreased
2.8M
-1.1%
$131.6M0.6%$47.03
0
2025-Q2
Increased
2.8M
+1.1%
$147.4M0.7%$51.88
43
2025-Q1
Decreased
2.8M
-0.4%
$169.1M0.8%$59.94
0
2024-Q4
Increased
2.8M
+0.9%
$192.3M0.9%$67.70
43
2024-Q3
Decreased
2.8M
-1.2%
$200.2M0.9%$70.94
0

Other major holders of CNMD: BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used